UBS Group Portfolio holdings
UBS Group AG, formed through the 1998 merger of Union Bank of Switzerland and Swiss Bank Corporation with roots dating back to 1862, is a Swiss multinational investment bank and financial services firm headquartered in Zurich. Renowned for its dominance in wealth management, UBS serves high-net-worth individuals and families globally, managing trillions in assets, while also offering investment banking, asset management, and retail banking services in Switzerland. The firm has weathered significant challenges, including a major bailout during the 2008 financial crisis, but has since refocused on stability and sustainable growth, emphasizing digital transformation and ESG (environmental, social, governance) investing. With a strong European base and a global reach, UBS remains a cornerstone of the international financial landscape.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$1.26B |
| 2 |
Strategy Inc
MSTR
|
+$745M |
| 3 |
EA
Electronic Arts
EA
|
+$725M |
| 4 |
TotalEnergies
TTE
|
+$639M |
| 5 |
Walmart Inc
WMT
|
+$585M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
NVIDIA
NVDA
|
+$1.87B |
| 2 |
Apple
AAPL
|
+$1.41B |
| 3 |
Microsoft
MSFT
|
+$1.16B |
| 4 |
iShares Core S&P 500 ETF
IVV
|
+$1.03B |
| 5 |
Southwest Airlines
LUV
|
+$727M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 17.52% |
| 2 | Financials | 9.54% |
| 3 | Healthcare | 6.68% |
| 4 | Industrials | 6.61% |
| 5 | Consumer Discretionary | 6.41% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
3901
Live Oak Bancshares
LOB
$1.95B
| $5.52M | ﹤0.01% |
160,710
+36,525
| +29% | +$1.22M |
|
3902
Castle Biosciences
CSTL
$988M
| $5.52M | ﹤0.01% |
141,873
-149,489
| -51% | -$4.82M |
|
3903
US Treasury 12 Month Bill ETF
OBIL
$307M
| $5.52M | ﹤0.01% |
109,942
+36,357
| +49% | +$1.83M |
|
3904
United Natural Foods
UNFI
$2.8B
| $5.52M | ﹤0.01% |
163,877
-19,133
| -10% | -$711K |
|
3905
Nuvation Bio
NUVB
$2.32B
| $5.51M | ﹤0.01% |
615,402
-292,699
| -32% | -$1.81M |
|
3906
Delek Logistics
DKL
$3.15B
| $5.51M | ﹤0.01% |
123,564
+8,649
| +8% | +$388K |
|
3907
Global Net Lease
GNL
$1.95B
| $5.51M | ﹤0.01% |
640,985
+117,400
| +22% | +$941K |
|
3908
First Financial Corp
THFF
$962M
| $5.51M | ﹤0.01% |
91,134
-14,025
| -13% | -$808K |
|
|
HTO
3909
H2O America
HTO
$2.56B
| $5.51M | ﹤0.01% |
112,387
-14,339
| -11% | -$688K |
|
3910
Preferred Bank
PFBC
$1.25B
| $5.51M | ﹤0.01% |
58,300
-24,983
| -30% | -$2.33M |
|
3911
UroGen Pharma
URGN
$2.26B
| $5.5M | ﹤0.01% |
235,040
+54,580
| +30% | +$1.18M |
|
3912
Community Trust Bancorp
CTBI
$1.41B
| $5.5M | ﹤0.01% |
97,393
+9,527
| +11% | +$526K |
|
3913
Sonos
SONO
$1.83B
| $5.5M | ﹤0.01% |
313,158
-142,767
| -31% | -$2.49M |
|
3914
State Street SPDR S&P International Small Cap ETF
GWX
$914M
| $5.5M | ﹤0.01% |
134,581
+2,582
| +2% | +$104K |
|
3915
IPG Photonics
IPGP
$3.61B
| $5.5M | ﹤0.01% |
76,792
-14,280
| -16% | -$1.17M |
|
3916
Gossamer Bio
GOSS
$86.1M
| $5.49M | ﹤0.01% |
1,771,381
-998,665
| -36% | -$2.85M |
|
3917
PUT
Constellation Brands
STZ
$22.8B
| $5.49M | ﹤0.01% |
39,800
-18,300
| -31% | -$2.51M |
|
3918
Stratasys
SSYS
$769M
| $5.49M | ﹤0.01% |
632,518
+294,908
| +87% | +$2.92M |
|
3919
iShares JPMorgan EM High Yield Bond ETF
EMHY
$636M
| $5.48M | ﹤0.01% |
135,831
+47,669
| +54% | +$1.91M |
|
3920
Tarsus Pharmaceuticals
TARS
$2.97B
| $5.48M | ﹤0.01% |
66,899
-51,663
| -44% | -$3.86M |
|
3921
PUT
Lumen
LUMN
$6.85B
| $5.48M | ﹤0.01% |
704,900
-240,800
| -25% | -$1.98M |
|
3922
Fidelity MSCI Communication Services Index ETF
FCOM
$1.79B
| $5.47M | ﹤0.01% |
74,672
+1,730
| +2% | +$123K |
|
3923
CALL
Williams Companies
WMB
$87.9B
| $5.46M | ﹤0.01% |
90,900
-187,100
| -67% | -$11.3M |
|
3924
Sasol
SSL
$7.38B
| $5.44M | ﹤0.01% |
835,052
+285,807
| +52% | +$1.81M |
|
|
ROBN
3925
T-Rex 2X Long HOOD Daily Target ETF
ROBN
$99.1M
| $5.43M | ﹤0.01% |
100,308
+50,308
| +101% | +$4.15M |
|
Similar funds
UBS Group's Q4 2025 Portfolio in Review
As of Q4 2025, UBS Group held 11,616 positions worth $617B, down 3.4% from $638B the previous quarter. Its ten largest holdings account for 15% of the portfolio.
UBS Group withdrew a net $32.7B in Q4 2025, closing 1,184 positions and reducing 4,502 holdings. Its most notable exit was Kellanova, an estimated $617M position sold in full.
By sector, the portfolio is most concentrated in Technology at 18% of assets, down from 18% a quarter earlier, followed by Financials and Healthcare.
Against the trend, UBS Group opened a new position in Solstice Advanced Materials worth $130M.
- UBS Group's largest Q4 2025 buy was Solstice Advanced Materials: 2,681,543 shares worth $130M.
- UBS Group added most to State Street SPDR S&P 500 ETF Trust in Q4 2025, an estimated $1.26B increase.
- UBS Group's biggest Q4 2025 reduction was NVIDIA, cutting an estimated $1.87B.
- UBS Group fully exited Kellanova in Q4 2025, selling an estimated $617M.
- UBS Group's ten largest holdings make up 15% of its $617B portfolio in Q4 2025.
- UBS Group opened 1,319 new positions and closed 1,184 in Q4 2025.
- UBS Group's portfolio value fell 3.4% quarter-over-quarter to $617B.
Based on UBS Group's 13F filing for Q4 2025, filed 29 Jan 2026.